2024 annual financial data
Xenetic Biosciences 2024 Net margin
Direct answer
Net margin was -158.39%.
Operating income was -4,204,428 USD and net income was -3,960,275 USD.
Operating cash flow was -2,817,478 USD.
Get free Xenetic Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,500,284 USD
- Operating income
- -4,204,428 USD
- Net income
- -3,960,275 USD
- Operating cash flow
- -2,817,478 USD